Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ICUI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 2.152B
March 31, 2026 2.112B
December 31, 2025 2.124B
September 30, 2025 2.127B
June 30, 2025 2.116B
March 31, 2025 1.988B
December 31, 2024 1.965B
September 30, 2024 2.049B
June 30, 2024 2.038B
March 31, 2024 2.068B
December 31, 2023 2.123B
September 30, 2023 2.098B
June 30, 2023 2.115B
March 31, 2023 2.100B
December 31, 2022 2.090B
September 30, 2022 2.013B
June 30, 2022 2.086B
March 31, 2022 2.179B
December 31, 2021 1.616B
September 30, 2021 1.590B
June 30, 2021 1.557B
March 31, 2021 1.521B
December 31, 2020 1.502B
September 30, 2020 1.452B
June 30, 2020 1.412B
Date Value
March 31, 2020 1.376B
December 31, 2019 1.377B
September 30, 2019 1.340B
June 30, 2019 1.318B
March 31, 2019 1.283B
December 31, 2018 1.264B
September 30, 2018 1.260B
June 30, 2018 1.257B
March 31, 2018 1.230B
December 31, 2017 1.198B
September 30, 2017 1.142B
June 30, 2017 1.121B
March 31, 2017 1.142B
December 31, 2016 660.16M
September 30, 2016 648.48M
June 30, 2016 616.23M
March 31, 2016 595.91M
December 31, 2015 579.87M
September 30, 2015 567.17M
June 30, 2015 538.06M
March 31, 2015 518.10M
December 31, 2014 508.25M
September 30, 2014 491.43M
June 30, 2014 485.47M
March 31, 2014 474.21M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Baxter International, Inc. 6.206B
Becton, Dickinson & Co. 24.42B
Boston Scientific Corp. 24.93B
Glaukos Corp. 682.49M
Medline, Inc. 11.57B

Shareholders Equity (Quarterly) Related Metrics